Complete myocardial revascularization: Between myth and reality

European Heart Journal

Volumn 26, Issue 18, 2005, Pages 1824-1830

  Zimarino, Marco ^a   Calafiore, Antonio Maria ^b   De Caterina, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Angioplasty; Coronary artery bypass surgery; Revascularization; Stents

Indexed keywords

CLINICAL FEATURE; CORONARY ARTERY DISEASE; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE; HOSPITAL CARE; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS; CORONARY DISEASE; DISEASE-FREE SURVIVAL; HUMANS; KIDNEY DISEASES; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; STENTS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24344449665     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi249     Document Type: Review

References (71)

1. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants. Lancet 1995;346:1179-1184.
2. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996;335:217-225.
3. van den Brand MJ, Rensing BJ, Morel MA et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-564.
4. Hoffman SN, TenBrook JA, Wolf MP et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003;41:1293-1304.
5. Calafiore AM, Di Giammarco G, Luciani N et al. Composite arterial conduits for a wider arterial myocardial revascularization. Ann Thorac Surg 1994;58:185-190.
6. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 2001;358:870-875.
7. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
8. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
9. Serruys PW, de Feyter P, Macaya C et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287:3215-3222.
10. Mehta SR, Yusuf S, Peters RJ et al. Effects of pretreatment with clopidogrel and aspirin followed by long- term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533.
11. Cannon CP, Weintraub WS, Demopoulos LA et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
12. Serruys PW, Unger F, Sousa JE et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
13. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002;360:965-970.
14. Legrand VM, Serruys PW, Linger F et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 2004;109:1114-1120.
15. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997;18:394-413.
16. Smith SC Jr, Dove JT, Jacobs AK et al. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i-lxvi.
17. Bertrand ME, Simoons ML, Fox KA et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-1840.
18. Eagle KA, Guyton RA, Davidoff R et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110:e340-e437.
19. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-580.
20. Botas J, Stadius ML, Bourassa MG et al. Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the Bypass Angioplasty Revascularization Investigation study (BARI). Am J Cardiol 1996;77:805-814.
21. Lavee J, Rath S, Tran Quang H et al. Does complete revascularization by the conventional method truly provide the best possible results? Analysis of results and comparison with revascularization of infarct-prone segments (systematic segmental myocardial revascularization): the Sheba Study. J Thorac Cardiovasc Surg 1986;92:279-290.
22. Vandormael MG, Chaitman BR, Ischinger T et al. Immediate and short-term benefit of multilesion coronary angioplasty: influence of degree of revascularization. J Am Coll Cardiol 1985;6:983-991.
23. Kip KE, Bourassa MG, Jacobs AK et al. Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;100:910-917.
24. Scott R, Blackstone EH, McCarthy PM et al. Isolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary artery: late consequences of incomplete revascularization. J Thorac Cardiovasc Surg 2000;120:173-184.
25. Ellis SG, Chew D, Chan A et al. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 2002;106:1205-1210.
26. Saito S, Tanaka S, Hiroe Y et al. Angioplasty for chronic total occlusion by using tapered-tip guidewires. Catheter Cardiovasc Interv 2003;59:305-311.
27. Freeman RV, O'Donnell M, Share D et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002;90:1068-1073.
28. Christenson JT, Simonet F, Schmuziger M. The impact of a short interval (< or =1 year) between primary and reoperative coronary artery bypass grafting procedures. Cardiovasc Surg 1996;4:801-807.
29. Bourassa MG, Kip KE, Jacobs AK et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999;33:1627-1636.
30. Vander Salm TJ, Kip KE, Jones RH et al. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2002;39:565-572.
31. Goldstein JA, Demetriou D, Grines CL et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-922.
32. Neumann FJ, Kastrati A, Pogatsa-Murray G et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003;290:1593-1599.
33. Mariani G, De Servi S, Dellavalle A et al. Complete or incomplete percutaneous coronary revascularization in patients with unstable angina in stent era: Are early and one-year results different? Catheter Cardiovasc Interv 2001;54:448-453.
34. Hanratty CG, Koyama Y, Rasmussen HH et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol 2002;40:911-916.
35. Gibson CM, Ryan KA, Murphy SA et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999;34:974-982.
36. O'Keefe JH, Blackstone EH, Sergeant P et al. The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery. Eur Heart J 1998;19:1696-1703.
37. Rozenman Y, Sapoznikov D, Mosseri M et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol 1997;30:1420-1425.
38. Loutfi M, Mulvihill NT, Boccalatte M et al. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients. Catheter Cardiovasc Interv 2003;58:451-454.
39. Graham MM, Ghali WA, Faris PD et al. Survival after coronary revascularization in the elderly. Circulation 2002;105:2378-2384.
40. Pfisterer M, Buser P, Osswald S et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA 2003;289:1117-1123.
41. Osswald BR, Tochtermann U, Schweiger P et al. Does the completeness of revascularization contribute to an improved early survival in patients up to 70 years of age? Thorac Cardiovasc Surg 2001;49: 373-377.
42. Jones EL, Weintraub WS. The importance of completeness of revascularization during long-term follow-up after coronary artery operations. J Thorac Cardiovasc Surg 1996;112:227-237.
43. Kilo J, Baumer H, Czerny M et al. Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients. Ann Thorac Surg 2001;71:537-542.
44. Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-1158.
45. Bax JJ, Wijns W, Cornel JH et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-1460.
46. Trachiotis GD, Weintraub WS, Johnston TS et al. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg 1998;66:1632-1639.
47. Kleikamp G, Maleszka A, Reiss N et al. Determinants of mid- and long-term results in patients after surgical revascularization for ischemic cardiomyopathy. Ann Thorac Surg 2003;75:1406-1412; discussion 1412-1413.
48. Sciagra R, Pellegri M, Pupi A et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-745.
49. Sciagra R, Leoncini M, Cannizzaro G et al. Predicting revascularization outcome in patients with coronary artery disease and left ventricular dysfunction (data from the SEMINATOR study). Am J Cardiol 2002;89:1369-1373.
50. Durmaz I, Yagdi T, Calkavur T et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 2003;75:859-864.
51. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349:1333-1340.
52. Keeley EC, Kadakia R, Soman S et al. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003;92:509-514.
53. Jeremias A, Albirini A, Ziada KM et al. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. Am Heart J 2002;143:1040-1045.
54. Brown KA, Rowen M. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 1993;21:325-330.
55. Darbar D, Gillespie N, Main G et al. Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease. Am J Cardiol 1996;78:736-740.
56. McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795-2804.
57. Moscucci M, Eagle KA. Coronary revascularization before noncardiac surgery. N Engl J Med 2004;351:2861-2863.
58. Landesberg G, Mosseri M, Wolf YG et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation 2003;108:177-183.
59. Wilson SH, Fasseas P, Orford JL et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-240.
60. Calafiore AM, Di Mauro M, Contini M et al. Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome. Ann Thorac Surg 2001;72:456-462; discussion 462-463.
61. Selvanayagam JB, Petersen SE, Francis JM et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004;109:345-350.
62. Khan NE, De Souza A, Mister R et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004;350:21-28.
63. Athanasiou T, Al-Ruzzeh S, Kumar P et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004;77:745-753.
64. Calafiore AM, Angelini GD, Bergsland J et al. Minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1996;62:1545-1548.
65. Diegeler A, Thiele H, Falk V et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med 2002;347:561-566.
66. Zimarino M, Gallina S, Di Fulvio M et al. Intraoperative ischemia and long-term events after minimally invasive coronary surgery. Ann Thorac Surg 2004;78:135-141.
67. Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
68. Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
69. Serruys PW. The Arterial Revascularization Therapies Study (ARTS) Part II: sirolimus-eluting Bx velocity stent for the treatment of multivessel de novo coronary artery lesions. TCT Meeting, 27 September 2004-1 October 2004, Washington, DC.
70. Ferreira AC, Peter AA, Salerno TA et al. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center. Ann Thorac Surg 2003;75:485-489.
71. Cohen DJ, Bakhai A, Shi C et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the sirolimus-eluting balloon expandable stent in the treatment of patients with de novo native coronary artery lesions (SIRIUS) trial. Circulation 2004;110:508-514.